COMPREHENSIVE ANALYSIS OF CLINICAL TRIALS IN PAKISTAN FROM SEPTEMBER 1992 TO FEBRUARY 2019

Authors

  • Amna Siddique Loyola Medicine Hospital
  • Amara Zafar DOW University of Health SciencesCivil Hospital Karachi.
  • Tooba Irfan DOW University of Health Sciences Civil Hospital Karachi.

DOI:

https://doi.org/10.55519/JAMC-03-8793

Abstract

Background: Clinical trials are conducted to evaluate interventions (drugs, medical devices, surgical methods and radiation treatment) for treating diseases or conditions. They may also be done to prevent the development or prevent recurrence or determining risk factors. We wanted to review the current status of clinical trials in Pakistan. Methods: On searching ClinicalTrials.gov, registered clinical trials conducted in Pakistan from September 1992 to February 2019 were reviewed. The analysis evaluated the characteristics of the clinical studies including the type of intervention, geographic distribution of studies, anticipated enrolment and number of participants, blinding, allocation status, lead sponsors, age group, study type, recruitment status, gender, study results, study phase, primary purpose and subject distribution. The results were tabulated with frequencies and percentages provided by category. Results: There were 508 registered clinical trials conducted in Pakistan from September 1992 to February 2019. Interventional clinical trials were conducted more often than observational trials (77.2% and 22.8% respectively), with drugs (41.4%) as the most common intervention. The majority of registered trials had participants ranging between 101-1000 (47.2%) with most having no blinding in their methodology (34.1%). Most of the trials conducted were randomized (66.5%) while few (5.3%) were non-randomized. Among the sponsor categories, 66.5% of the trials belong to the ‘Other’ (non-governmental, non-industry) category. Although 59.6% of the registered trials have been completed, most of them (91.3%) did not report their results. Treatment intervention trials in Internal Medicine were the most common primary purpose. An increasing trend in the frequency of clinical trials was also evident. Conclusion: The number of clinical trials in Pakistan showed an increasing trend over the time period studied, which may reflect on the general outlook of clinical research in the country. Most clinical trials were sponsored by universities, hospitals and non-profit organizations but less than 10% of studies reported results

Author Biographies

Amna Siddique, Loyola Medicine Hospital

Resident Physician

Amara Zafar, DOW University of Health SciencesCivil Hospital Karachi.

Intern

Tooba Irfan, DOW University of Health Sciences Civil Hospital Karachi.

Intern

References

Learn About Clinical Studies - ClinicalTrials.gov [Internet]. [cited 2019 April 15]. Available from: https://clinicaltrials.gov/ct2/about-studies/learn

Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn’t. BMJ 1996;312(7023):71–2.

Sibbald B, Roland M. Understanding controlled trials. Why are randomised controlled trials important? BMJ 1998;316(7126):201.

The James Lind Library - Illustrating the development of fair tests of treatments in health care [Internet]. The James Lind Library. [cited 2019 April 15]. Available from: https://www.jameslindlibrary.org/

Woolf SH. The meaning of translational research and why it matters. JAMA 2008;299(2):211–3.

Kendall JM. Designing a research project: randomised controlled trials and their principles. Emerg Med J 2003;20(2):164–8. Ref no 6&17 are same

McCray AT, Ide NC. Design and implementation of a national clinical trials registry. J Am Med Inform Assoc 2000;7(3):313–23.

National Institutes of Health Launches ClinicalTrials.gov Results Database. [Internet]. [cited 2019 April 15]. Available from: http://www.nlm.nih.gov/news/expanded_clinicaltrials.html

Gillen JE, Tse T, Ide NC, McCray AT. Design, implementation and management of a web-based data entry system for ClinicalTrials.gov. Stud Health Technol Inform 2004;107(Pt 2):1466–70.

Zarin DA, Tse T, Ide NC. Trial registration at ClinicalTrials.gov between May and October 2005. N Engl J Med 2005;353(26):2779–87.

Zarin DA, Ide NC, Tse T, Harlan WR, West JC, Lindberg DA. Issues in the registration of clinical trials. JAMA 2007;297(19):2112–20.

The Word Bank, Pakistan Data. [Internet]. [cited 2019 April 15]. Available from: https://data.worldbank.org/country/pakistan

Pakistan Population (2021) - Worldometer [Internet]. [cited 2019 April 15]. Available from: https://www.worldometers.info/world-population/pakistan-population/

Current health expenditure (% of GDP) - Pakistan | Data [Internet]. [cited 2019 April 15]. Available from: https://data.worldbank.org/indicator/SH.XPD.CHEX.GD.ZS?locations=PK&name%20desc=false

Global Health Observatory. 2013. Pakistan: Country Profile. Geneva, Switzerland: World Health Organization. [Internet]. [cited 2019 April 15]. Available from: http://www.who.int/gho/countries/pak/en/

Irumnaz A, C Nair S. Clinical trials in Pakistan: Opportunities and challenges. Appl Clin Res Clin Trials Regul Aff 2014;1(1):23–7.

Kendall JM. Designing a research project: randomised controlled trials and their principles. Emerg Med J 2003;20(2):164–8. Ref no 6&17 are same

Califf RM, Zarin DA, Kramer JM, Sherman RE, Aberle LH, Tasneem A. Characteristics of clinical trials registered in Clinical Trials. gov, 2007-2010. JAMA 2012;307(17):1838–47.

Kris MG, Meropol NJ, Winer EP. Accelerating progress against cancer: ASCO’s blueprint for transforming clinical and translational cancer research. [Internet]. American Society of Clinical Oncology. [cited 2012 Feb 5]. Available from: http://www.asco.org/ascov2/department%20content/cancer%20policy%20and%20clinical%20affairs/downl oads/blueprint.pdf

Yusuf S, Collins R, Peto R. Why do we need some large, simple randomized trials? Stat Med 1984;3(4):409–22.

Peto R, Collins R, Gray R. Large-scale randomized evidence: large, simple trials and overviews of trials. J Clin Epidemiol 1995;48(1):23–40.

Califf RM, DeMets DL. Principles from clinical trials relevant to clinical practice: part I. Circulation 2002;106(8):1015–21.

Jawad F. Clinical trial registry in Pakistan. [Internet]. [cited 2019 April 15]. Available from: https://jpma.org.pk/article-details/8802

Research and Development at GSK Pakistan - GlaxoSmithKlinec2001-2010. [Internet]. [cited 2013 Nov 21] Available from: http://www.gsk.com.pk/Research-and-Development/73/Researchand-Development-at-GSK-Pakistan. aspx

Zwierzyna M, Davies M, Hingorani AD, Hunter J. Clinical trial design and dissemination: comprehensive analysis of clinical trials. gov and PubMed data since 2005. BMJ 2018;361:k2130.

Osama M, Malik RJ, Azim ME. Clinical Trial Registry: An essential requirement for physical therapy and health researchers in Pakistan. J Pak Med Assoc 2018;68(7):1079–83.

Sherin A. Clinical trial registration: Can we establish a national clinical trial registry of Pakistan? Khyber Med J Univ J 2012;4(2):37–8.

Downloads

Published

2022-06-21